Titan Pharmaceuticals

+$0.0051 (+0.88%) Today
+$0.0441 (+7.54%) As of 9:05 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TTNP and other ETFs, options, and stocks.

About TTNP

Titan Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, ProNeura. Its lead product is Probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction.

CEO
Sunil Bhonsle, MBA
Employees
11
Headquarters
South San Francisco, California
Founded
1992

TTNP Key Statistics

Market cap
7.80M
Price-Earnings ratio
—
Dividend yield
—
Average volume
252.94K
High today
$0.6566
Low today
$0.571
Open price
$0.59
Volume
537.48K
52 Week high
$3.10
52 Week low
$0.3496

TTNP Earnings

-$1.50
-$1.00
-$0.50
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 15, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure